Shell Asset Management Co. Boosts Stock Position in Kenvue Inc. (NYSE:KVUE)

Shell Asset Management Co. boosted its position in shares of Kenvue Inc. (NYSE:KVUE) by 68.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,606 shares of the company’s stock after buying an additional 10,378 shares during the quarter. Shell Asset Management Co.’s holdings in Kenvue were worth $547,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Handelsbanken Fonder AB boosted its stake in Kenvue by 2.9% during the fourth quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company’s stock worth $15,846,000 after buying an additional 21,222 shares during the period. Alberta Investment Management Corp boosted its stake in Kenvue by 23.2% during the fourth quarter. Alberta Investment Management Corp now owns 582,895 shares of the company’s stock worth $12,445,000 after buying an additional 109,700 shares during the period. Longbow Finance SA boosted its stake in Kenvue by 5.0% during the fourth quarter. Longbow Finance SA now owns 280,568 shares of the company’s stock worth $5,990,000 after buying an additional 13,287 shares during the period. Steward Partners Investment Advisory LLC boosted its stake in shares of Kenvue by 143.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company’s stock valued at $1,023,000 after purchasing an additional 28,216 shares during the period. Finally, CORDA Investment Management LLC. boosted its stake in shares of Kenvue by 1.4% during the fourth quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company’s stock valued at $26,754,000 after purchasing an additional 17,466 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on KVUE. UBS Group boosted their target price on shares of Kenvue from $24.00 to $25.00 and gave the company a “neutral” rating in a research note on Friday, May 9th. Barclays boosted their target price on shares of Kenvue from $22.00 to $23.00 and gave the company an “equal weight” rating in a research note on Monday, May 12th. Canaccord Genuity Group boosted their target price on shares of Kenvue from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Wednesday, March 5th. Royal Bank of Canada reissued a “sector perform” rating and set a $24.00 target price on shares of Kenvue in a research note on Monday, February 3rd. Finally, Redburn Atlantic began coverage on shares of Kenvue in a research note on Thursday, April 10th. They set a “neutral” rating and a $23.50 target price for the company. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $25.33.

Kenvue Stock Up 1.1%

NYSE:KVUE opened at $24.15 on Monday. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $25.17. The company has a 50-day moving average of $23.16 and a 200 day moving average of $22.59. The firm has a market cap of $46.34 billion, a PE ratio of 45.57, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The company had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. During the same period in the prior year, the firm earned $0.28 earnings per share. The firm’s revenue for the quarter was down 3.9% compared to the same quarter last year. As a group, research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be issued a $0.205 dividend. The ex-dividend date is Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a yield of 3.40%. Kenvue’s dividend payout ratio is presently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.